Valvular dysfunction and cardiovascular risk in individuals with opioid use disorder who are maintained on buprenorphine/naloxone: a focus on pan-immune-inflammation value and uric acid-to-albumin ratio
This study underscores the potential of PIV and UAR as predictive markers for cardiac pathologies in individuals undergoing buprenorphine/naloxone maintenance therapy, highlighting the need for further validation in larger prospective studies.
Authors
- Selver Can (ORCID: https://orcid.org/0000-0002-5370-9422)
- Sinan Kahraman (ORCID: https://orcid.org/0000-0003-3408-7389)
- Ahmet Taha Şahin (ORCID: https://orcid.org/0000-0002-2928-1059)
- Hatice Eyiol (ORCID: https://orcid.org/0000-0001-6558-9344)
- Azmi Eyiol (ORCID: https://orcid.org/0000-0003-2740-1966)
Institutions
- Konya Eğitim ve Araştırma Hastanesi (TR)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-12-18
- DOI
- https://doi.org/10.3389/fcvm.2025.1612190
- Citations
- 1
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.88